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Abstract
Background. Experimental studies suggest that mechanical cell washing to remove pro-inflammatory components that ac-
cumulate in the supernatant of stored donor red blood cells (RBCs) might reduce inflammation and organ injury in trans-
fused patients.
Methods. Cardiac surgery patients at increased risk of large-volume RBC transfusion were eligible. Participants were
randomized to receive either mechanically washed allogenic RBCs or standard care RBCs. The primary outcome was serum
interleukin-8 measured at baseline and at four postsurgery time points. A mechanism substudy evaluated the effects of
washing on stored RBCs in vitro and on markers of platelet, leucocyte, and endothelial activation in trial subjects.
Results. Sixty adult cardiac surgery patients at three UK cardiac centres were enrolled between September 2013 and March
2015. Subjects received a median of 3.5 (interquartile range 2–5.5) RBC units, stored for a mean of 21 (SD 5.2) days, within 48h
of surgery. Mechanical washing reduced concentrations of RBC-derived microvesicles but increased cell-free haemoglobin
concentrations in RBC supernatant relative to standard care RBC supernatant. There was no difference between groups with
respect to perioperative serum interleukin-8 values [adjusted mean difference 0.239 (95% confidence intervals 0.231, 0.709),
P¼0.318] or concentrations of plasma RBCmicrovesicles, platelet and leucocyte activation, plasma cell-free haemoglobin,
endothelial activation, or biomarkers of heart, lung, or kidney injury.
Conclusions. These results do not support a hypothesis that allogenic red blood cell washing has clinical benefits in cardiac
surgery.
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Cardiovascular
Organ injury associated with red blood cell (RBC) transfusion
has been attributed to a ‘storage lesion’; a progressive disrup-
tion of erythrocyte homeostasis associated with depletion of
high-energy phosphates during storage that results in accumu-
lation of microparticles and other inflammatory substances in
the supernatant of RBCs.1 Experimental studies implicate plate-
let and monocyte activation by RBC microparticles, and endo-
thelial dysfunction as a consequence of altered haem
metabolism, in transfusion-associated organ injury,2–5 and sug-
gest that removal of the storage supernatant by cell washing at-
tenuates inflammatory responses and organ dysfunction.2 6 In
support of these findings, washing of allogeneic RBCs has been
shown to attenuate inflammation in children undergoing car-
diac surgery.7 We tested the hypothesis that allogeneic RBC
washing attenuates inflammation and organ failure in adult
cardiac surgery patients receiving large-volume transfusions. In
a prespecified substudy, we tested the hypothesis that RBC
washing attenuates platelet and leucocyte activation by remov-
ing inflammatory RBCmicroparticles. We also assessed whether
cell-free haemoglobin (Hgb) release by RBCs after washing re-
sults in endothelial activation.
Methods
The Red Cell Washing for the Attenuation of Organ Injury
Following Cardiac Surgery (REDWASH) trial was a multicentre,
single-blinded, parallel-group, randomized controlled trial of
washing of allogeneic RBCs before transfusion vs standard
care (no washing). The trial had ethical approval (REC Reference
12/EM/0475) and was registered (ISRCTN 27076315). The trial
protocol has been published;8 changes to the study design after
trial commencement are listed in the online Supplementary
material. The main trial was terminated by the funder in March
2015 because of slow recruitment. This report includes the re-
sults of a prespecified mechanistic substudy planned for the
first 60 patients recruited.8 A detailed description of the study
methods is available as online Supplementary material.
Patients
Adults (16 yr of age) undergoing cardiac surgery with blood
cardioplegia identified as representing a high-risk group for
large-volume blood transfusion (LVBT) using a modified risk
score9 (score25) were eligible for inclusion. Exclusion criteria
are listed in Supplementary Table S1.
Randomization and blinding
Subjects were randomly assigned with concealed allocation
using an Internet-based randomization system (Sealed
Envelope Ltd, Medicines Healthcare Regulatory Authority
(MHRA) recognized facility). Randomization was stratified by
study site and type of procedure. Outcome assessors were
blinded to allocation.
Intervention
Eligible subjects who consented to participate were randomly
allocated, in a 1:1 ratio, to receive either standard care
(unwashed prestorage leucodepleted allogenic red blood cells)
or washed red blood cells, between the commencement of sur-
gery and 48h after surgery. Allogeneic saline–adenine–glucose–
mannitol (SAGM) stored RBC units used in the trial were issued
by National Health Service Blood and Transplant (NHSBT) as per
standard care. The Continuous AutoTransfusion System
(CATSTM; Fresenius AG, Bad Homburg, Germany) was used on
the basis that low g force centrifugation with this device minim-
izes RBC trauma.10 11 For the intervention, RBCs were washed in
theatre or at the patient’s bedside with saline using the Quality
Mode and immediately administered to the patient. Washed
units were not stored for future use. The haematocrit threshold
for transfusion was 23. A major protocol violation was defined
as receipt of only unwashed blood for subjects randomized to
receive washed RBCs, or the receipt of only washed blood in pa-
tients randomized to receive standard care.
Outcomes
The primary outcome was severity of the systemic inflamma-
tory response as indicated by serum interleukin (IL)-8 measured
at baseline and at four postsurgery time points. We have previ-
ously shown that IL-8 is increased in transfused patients.8 12
Secondary outcomes are described in Supplementary Table S2.
For the mechanism study, serum, platelet-poor plasma, and
urine samples were collected at baseline and a serial time
points. Microparticles in storage supernatant and platelet-poor
plasma were characterized using flow cytometry (Cyan ADP;
Beckman Coulter, Brea, CA USA). Cell-free Hgb and plasma total
and non-transferrin-bound iron were measured in the super-
natant of RBC units and in plasma as described.13–15 Platelet ac-
tivation [platelet activating complex (PAC)-1 (BD Biosciences,
Abingdon, Oxford, UK), P selectin/CD62P (Abcam, Cambridge,
UK), and PE-coupled CD41 (Affymetrix, Santa Clara, CA, USA)]
and leucocyte activation markers (CD64, CD163; Affymetrix)
were measured using flow cytometry (Cyan ADP; Beckman
Coulter) in whole blood. Platelet activation was also measured
indirectly in whole blood using Multiplate aggregometry (Roche
Diagnostics International Ltd, Rotkreuz, Switzerland). Serum
bilirubin was measured on the Siemens Advia 2400 Chemistry
System (Siemens, Frimley, UK). Hepcidin was measured using
an enzyme-linked immunosorbent assay (Abbexa, Cambridge,
UK). Serum intercellular adhesion molecule (ICAM)-1 was meas-
ured using multiplex assays on the MAGPIX (Luminex
Corporation, Austin, TX, USA). Reactive oxygen species concen-
trations, protein carbonyl content, and thiobutiric acid reactive
substances (TBARS) were measured with the following commer-
cially available kits: OxiSelect (Cell Biolabs, Inc., San Diego, CA,
USA), Parameter TBARS assay (R&D Systems, Abingdon, Oxford,
UK), and carbonyl content assay kit (Abcam).
Editor’s key points
• Experimental evidence supports a benefit to red blood
cell (RBC) washing to reduce inflammatory factors be-
fore transfusion.
• In a randomized trial of washed and standard un-
washed RBCs in high-risk cardiac surgery patients, the
experimental benefit was not replicated.
• Owing to the limited power of this trial, larger studies
are necessary to test the hypothesis that RBC washing
is beneficial.
690 | Wozniak et al.
Statistical analyses
As trial recruitment was terminated early, the comparison of
the primary end point (IL-8) is reported here. Secondary out-
comes are reported in the online Supplementary material. The
mechanism substudy was exploratory; therefore, no sample
size calculation was performed. The analysis was performed on
an intention-to-treat basis on all randomized subjects who
entered the trial (underwent surgery) and had the primary out-
come measured at one time point or more (including baseline).
Data are presented as the mean (SD) for normally distributed
data, median (interquartile range, IQR) for non-normally distrib-
uted data, or n (%). Means for continuous outcomes for clinical
and experimental data (transformed logarithmically if required)
were compared using mixed effects models, adjusting for base-
line values where available. Treatment estimates were reported
as effect sizes with 95% confidence intervals (CIs). A statistical
analysis plan was written before database lock (see online
Supplementary material). The analysis was performed with SAS
version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Trial cohort
Sixty subjects were recruited and randomized at three UK
centres between May 2013 and March 2015. After withdrawals
(Fig. 1A), the analysis population comprised 29 allocated to the
standard care arm and 27 to the washing arm. There were four
severe protocol deviations, two in the standard care group and
two in the washing group. Fifty-four subjects were eligible for
follow-up at 3months. Overall, the mean age of participants
was 74yr [Range 51-90 years], and 28 (50.0%) were female
(Supplementary Table S3). Generally, there was good balance
between groups; however, by chance there was a lower baseline
estimated glomerular filtration rate (eGFR ml .min-1. 1.73m-2) in
the washing group [68 (24) vs 90 (30)] in the standard care arm.
The types of procedures and the bypass and cross-clamp times
were well matched between groups (Supplementary Table S4).
Transfusion and blood loss
The median number of units transfused was 3 (2–5) in the
standard care arm compared with 4 (2–6) in the washing arm
(P¼0.04; Supplementary Table S5). In the washing arm, one sub-
ject did not receive any red cells and two received only un-
washed RBCs. The distribution of timings (intra- vs
postoperative) of RBC transfusions was similar between groups
(Fig. 1B). The mean storage age of the RBCs was 20 (4.1) and 22
(5.6) days in the standard care and washing arms, respectively
(P¼0.078; Fig. 1C and Supplementary Table S5). There was no
difference between groups with respect to blood loss (4 and 12h;
Supplementary Table S5), serial haemoglobin concentrations
(Fig. 1D), or exposure to non-RBC blood components
(Supplementary Table S5).
Primary and secondary outcomes
There was no difference between groups for the primary out-
come, serum IL-8 [adjusted mean difference, standard vs wash-
ing, 0.239 (0.231, 0.709), P¼0.318; Fig. 2A]. There was no
difference between groups with respect to alternative bio-
markers of leucocyte and endothelial activation
(Supplementary Table S6). There was no difference between
groups with respect to MOD scores, worst MOD scores, serial
arterial partial pressure of oxygen/inspired oxygen fraction
(PaO2=FIO2 ) ratios, or serial troponin measurements (Fig. 2B–D).
Serial creatinine values and urinary neutrophil gelatinase-asso-
ciated lipocalcin values [logarithmically adjusted mean differ-
ence 0.435 (95% CI 0.022, 0.849), P¼0.039; Fig. 2E] were
significantly higher in the washing group, and calculated cre-
atinine clearance was lower (Fig. 2F). However, differences in
kidney function and injury were not statistically significant
when adjusted for the difference in baseline eGFR
(Supplementary Table S7). Clinical outcomes and resource use
in the analysis population and adverse events in the safety
population are reported for completeness16 in Supplementary
Tables S8 and S9..
Mechanism analyses
Effect of washing on stored RBCs
Microparticles positive for CD235a (glycophorin A, an RBC anti-
gen) and annexin V (AV), which labels phosphatidylserine and
oxidized lipids, accumulated in the supernatant of RBC units
throughout storage (Fig. 3A). Mechanical washing of RBCs sig-
nificantly reduced concentrations of CD235a/AV microparticle
and total microparticle concentrations in units stored for 41
(Fig. 3A) and 21 days (Fig. 3B). Cell-free Hgb concentrations also
increased progressively in the supernatant of RBCs during stor-
age (Fig. 3C). Mechanical washing did not reduce concentrations
of free Hgb in RBCs stored for 35 days (Fig. 3C) and doubled free
Hgb concentrations in RBCs stored for 21 days (Fig. 3D). Washing
did not significantly alter RBC adenosine triphosphate concen-
trations or osmotic fragility (Fig. 3D and E).
Effects of RBC washing on microparticles and platelet and leucocyte
activation
There was no difference between groups with respect to serial
measures of total, AV-positive, or RBC-derived (CD235a positive)
microparticles in plasma up to 48h postsurgery (Fig. 4A–C).
There was no difference between groups with respect to con-
centrations of CD64/CD163-positive (activated) leucocytes, PAC-
1, or CD40/CD62P-positive (activated) platelets, as determined
by flow cytometry (Fig. 4D–F), or platelet activation as assessed
by Multiplate aggregometry (data not shown).
Effects of RBC washing on cell-free haemoglobin, oxidative stress,
and endothelial activation
Plasma cell-free Hgb concentrations were increased signifi-
cantly in both washing and standard care groups immediately
postsurgery (Fig. 5A). However, there was no difference between
groups in plasma free Hgb, iron concentrations, serum haem-
atocrit, serum total bilirubin, non-transferrin-bound iron, hepci-
din concentrations, nitric oxide bioavailability, or indicators of
endothelial activation [serum ICAM-1 and CD144 (vascular
endothelial cadherin)-positive microparticles; Fig. 5B–H].
Specifically, endothelium-derived microparticles did not coex-
press integrin b1 (VLA5; Fig. 5I), a putative marker of haem-
mediated endothelial activation.
The greater part of plasma free Hgb immediately postsurgery
was probably not altered by RBC washing but was most probably
attributable to lysis of recipient RBCs by the cardiopulmonary
bypass (CPB) circuit. However, free Hgb released after washing
of stored RBCs is more reactive than that released by lysed fresh
RBCs, as generated by the CPB circuit (Fig. 5J), implying that
similar plasma free Hgb concentrations in groups might bely
qualitative differences in biological activity. However, we did
not detect differences in measures of oxidative stress in serum,
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Fig 1 (A) CONSORT diagram of REDWASH trial. (B) Haemoglobin concentrations [mean (SD)] in samples collected from REWASH participants. (C) Number of red
blood cell (RBC) units transfused during the trial, during cardiac surgery, and after surgery. (D) Histogram of the transfused RBC unit age distribution.
692 | Wozniak et al.
A IL8
Standard
PreOp ICU 12 h 24 h
PaO2/ F IO2
Pa
O
2
/F
I O
2 
ra
tio
48 h PreOp ICU 12 h 24 h
Troponin
NGAL Creatinine clearance
48 h
PreOp ICU 12 h 24 h 48 h 72 h 96 h
72 h 120 h
PreOp ICU 12 h 24 h
PreOp 12 h6 h 24 h 12 h6 h 24–48 h
48 h 72 h 120 h
90
600
500
400
300
200
4
2
0
pg
 m
l–
1
M
O
D 
sc
or
e
60
30
pg
 m
l–
1
60
40
m
l m
in
–
1
200
150
100
50
0
20
0
pg
 m
l–
1
30000
20000
10000
0
0
Washing
Standard
Washing
Standard
Washing
Standard
Washing
Standard
Washing
Standard
Washing
MODSB
C D
E F
Fig 2 Inflammation and organ injury. (A) Serum interleukin-8 (IL-8). (B) Multiple organ dysfunction scores (MODS). (C) Arterial partial pressure of oxygen/inspired
oxygen fraction (PaO2 =FIO2 ) ratio. (D) Serum troponin. (E) Urine neutrophil gelatinase-associated lipocalcin (NGAL). (F) Serum creatinine clearance. Values repre-
sent the mean (SD). Findings were not different in prespecified per protocol and safety analyses.
Allogenic red cell washing in cardiac surgery | 693
A B
C
E F
D
CD235a/AV postitve microparticles
Storage time (days)
Po
si
tiv
e 
M
P 
(%
)
20
D3 D6 D9 D13 D17 D22 D29 D34 D41 Wash
*
15
10
5
0
Microparticles at day 21
CD235a
CD235a/AV
Po
si
tiv
e 
M
P 
(%
)
8
6
4
2
0
Day 21 Wash
Cell-free Hgb at day 21
Day 21 Wash
*
m
g 
m
l–
1
0.15
0.10
0.05
0
RBC ATP
3000
Fl
uo
re
sc
en
ce
 (a
rbi
tra
ry 
un
its
)
2000
1000
0
Day 21 Wash
Cell free haemoglobin
m
g 
m
l–
1
Storage time (days)
D3 D6 D9 D13 D17 D22 D34 D35W
0.6
0.4
0.2
0
0.9
0.6
0.3
0
%
 o
f A
54
0n
m
 
in
 H
2O
Osmotic fragility
Day 21
Wash
0 0.3
NaCI concentration (M)
0.4 0.5 0.6 0.9
Fig 3 Effects of washing on the red blood cell (RBC) storage lesion in vitro. (A) Fractional changes in CD235a/annexin V (AV)-positive microparticles during storage
and after washing; eight RBC units were analysed. (B) Fractional changes in RBC-derived microparticles in 21-day-stored RBC bags in response to washing (6 units
analysed before and 3 units after washing). (C) Cell-free haemoglobin (Hgb) in washed RBC units. (D) Haemoglobin concentrations after washing at day 21.
(E) Adenosine triphosphate (ATP) concentrations in 21-day-old RBC bags before and after washing (6 units analysed before and 3 units after washing). (F) Osmotic
fragility of 21-day-old RBCs (6 units analysed). Values represent means (SD).
694 | Wozniak et al.
a putative mechanism by which free Hgb damages cells, as
measured by protein carbonylation or lipid peroxidation (Fig. 5K
and L).
Discussion
Red blood cell-derived (CD235a-positive) microparticles accumu-
late progressively in RBC units from the start of storage and are
effectively removed by mechanical washing. In the REDWASH
trial, however, transfusion of washed RBCs did not reduce
plasma concentrations of CD235a-positve microparticles or lev-
els of platelet or leucocyte activation in recipients compared
with standard RBCs. Cell-free Hgb also increases in the super-
natant of RBC units during storage and is increased by washing.
However, in the REDWASH trial there was no difference in
plasma free Hgb concentrations or markers of haem/iron metab-
olism, endothelial activation, or oxidative stress between groups.
This is the first randomized trial to evaluate the risks and
benefits of RBC washing in adults. We recruited a high-risk
population of cardiac surgery patients that should in principle
have benefited from safer RBC transfusion. Patients in both
groups received significant volumes of RBCs, 1000ml, within
48h of surgery and experienced significant morbidity; 86% of
patients experienced a composite clinical outcome of death,
sepsis, or organ failure. Subjects in the washing group received
more RBC units despite similar perioperative levels of blood loss
and serial serum haemoglobin concentrations. This is consist-
ent with previous clinical and experimental studies that report
loss of 10–25% of red cells during mechanical washing.6 10 The
chief limitations of the study are the limited power of our obser-
vations and the early termination of the main trial. For these
reasons, we can neither accept nor refute our primary hypothe-
ses. Furthermore, by chance, there was a difference in baseline
eGFR between the groups. These limitations notwithstanding,
the randomization generated two groups that received large vol-
umes of washed or unwashed RBCs and, after adjustment for
baseline eGFR, demonstrated no difference for any measured
biomarker of inflammation or organ injury. On balance, our
findings argue against important clinical benefits for RBC wash-
ing. The REDWASH trial did not evaluate immunomodulation,
and therefore, we are unable to comment on the effects of
washing on these processes. The results of a similar trial
(NCT02094118) evaluating the clinical efficacy of RBC washing
will provide greater insights into these results.
Experimental work has documented both potential risks and
benefits of RBC washing. We have shown that RBC-derived
microparticles activate platelets and leucocytes in vitro.
Furthermore, we have shown that mechanical RBC washing in a
swine model effectively removes microparticles and attenuates
platelet and leucocyte sequestration in lungs and the clinical
and histological correlates of transfusion-associated lung injury
( MJ Wozniak, GJ Murphy, unpublished observations). Likewise,
we have shown that cell-free Hgb activates endothelial cells by
a pathway previously described only in human aortic endothe-
lial cells in the presence of minimally modified low-density
lipoprotein.17 The activation is most probably mediated by lipids
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Fig 4 Effects of red blood cell (RBC) washing on microparticle concentrations and platelet and leucocyte activation. (A) Microparticle concentration in collected
plasma samples. (B and C) Fractional content of annexin V- (AV) and CD235a-positive microparticles in plasma samples. (D) Activation of monocytes measured
by expression of CD64 on monocytes (CD163). (E) Expression of integrin aIIb/b3 (PAC-1) on activated platelets. (F) Expression of CD62P on platelets (CD41). Values
represent means (SD).
Allogenic red cell washing in cardiac surgery | 695
oxidized by increased concentrations of free Hgb18 that occurs
either in the blood bags or after transfusion.19 Here, an alterna-
tive pathway results in VLA5 (integrin-a5/b1) expression, reten-
tion of alternatively spliced CS-1 fibronectin on the surface of
endothelial cells, and endothelial cell–monocyte interaction.20
In swine, as in humans, RBC washing results in accelerated re-
lease of cell-free Hgb, and this results in acute endothelial
injury, oxidative stress, and acute kidney injury in experimental
subjects (unpublished observations). Studies in human cells
have also highlighted potential sublethal damage to RBCs dur-
ing mechanical washing that could potentially offset any bene-
fits derived from reductions in RBC-derived microparticles.21
Our experimental results were not replicated in the
REDWASH trial. This could be attributable to differences
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between species, differences in the time period over which RBCs
were transfused, or both, in porcine experiments and trial sub-
jects. Typically, 4 units were transfused during 2h in swine,
whereas a similar volume, on average, was transfused during
2 days in the clinical trial. The porcine experiments were also
conducted without CPB. These factors might have diminished
the clinical benefits of washing; neither microparticle depletion
nor the release of free Hgb observed after washing was reflected
by differences in plasma microparticle concentrations or cell-
free Hgb in subjects or by differences in inflammation and organ
injury. Moreover, the peak mean IL-8 concentration in our por-
cine experiments after transfusion with older stored RBCs was
10pg ml1. In the standard care patients in the REDWASH trial,
the peak IL-8 concentration was 220pg ml1. We speculate that
the effects of washing were superseded by greater platelet and
leucocyte activation, free Hgb release, and endothelial injury at-
tributable to surgery and CPB.22 Alternatively, the mixed risks
and benefits from RBC washing might have resulted in no over-
all difference between trial groups. Manual washing techniques
that minimize RBC trauma are unlikely to address this limita-
tion because these are time consuming. Indeed, the delay
attendant on bedside washing contributed to protocol non-
compliance in the present study. An alternative is RBC rejuven-
ation.23 This maximizes the benefits of washing by preventing
production of microparticles after washing, minimizes risks by
preventing RBC damage and free Hgb release, and attenuate
transfusion-mediated organ injury in experimental studies
(unpublished observations).
In conclusion, the results of the mechanism substudy of the
REDWASH trial did not support our hypothesis that mechanical
washing of transfused RBCs would attenuate platelet and leuco-
cyte activation and organ injury in cardiac surgery patients.
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